Nontuberculous mycobacteria in patients with bronchiectasis: data from the German Bronchiectasis Registry PROGNOSIS

R. Ewen (Hannover, Germany), G. Barten-Neiner (Hannover, Germany), A. De Roux (Berlin, Germany), R. Diel (Kiel, Germany), P. Mertsch (Munich, Germany), J. Rademacher (Hannover, Germany), T. Welte (Hannover, Germany), A. Zurawski (Hannover, Germany), F. Ringshausen (Hannover, Germany), +. The Prognosis Study Group (Hannover, Germany)

Source: International Congress 2019 – Complex respiratory infections in clinical practice
Session: Complex respiratory infections in clinical practice
Session type: Thematic Poster
Number: 4584
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Ewen (Hannover, Germany), G. Barten-Neiner (Hannover, Germany), A. De Roux (Berlin, Germany), R. Diel (Kiel, Germany), P. Mertsch (Munich, Germany), J. Rademacher (Hannover, Germany), T. Welte (Hannover, Germany), A. Zurawski (Hannover, Germany), F. Ringshausen (Hannover, Germany), +. The Prognosis Study Group (Hannover, Germany). Nontuberculous mycobacteria in patients with bronchiectasis: data from the German Bronchiectasis Registry PROGNOSIS. 4584

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New isolation of non-tuberculous mycobacteria in patients with bronchiectasis - data from the European Bronchiectasis Registry (EMBARC)
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019

Phenotyping of adult patients with bronchiectasis and Yellow-Nail-Syndrome (YNS)- data from the German and the European Bronchiectasis Registries (PROGNOSIS and EMBARC)
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019


PROGNOSIS - the German Bronchiectasis Registry: first results
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017

Characteristics of patients with pulmonary non-tuberculous Mycobacterial infection in bronchiectasis: Data from the EMBARC registry
Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Year: 2018


Nontuberculous mycobacteria lung infection in bronchiectasis: Prevalence and clinical characteristics
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016


Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016

Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics
Source: Eur Respir J 2006; 28: 1204-1210
Year: 2006



A First Look at the Italian Registry on Pulmonary Non-Tuberculous Mycobacteria (NTM) -IRENE
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020


Allergic bronchopulmonary aspergillosis as aetiology of bronchiectasis: data from the German bronchiectasis registry PROGNOSIS
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020


Nontuberculous mycobacteria and aspergillus coexistence in pulmonary disease – Retrospective analysis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Etiology and outcome of bronchiectasis in children
Source: International Congress 2014 – Paediatric bronchology
Year: 2014


Prevalence of nontuberculosis mycobacterial in patients with bronchiectasis: A meta-analysis
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


International validation of FACED score in 672 patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016


Mediastinal nontuberculous mycobacteria (NTM) – A rare entity
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015


The Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease in Japan
Source: International Congress 2017 – Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections
Year: 2017



Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

Non-tuberculous mycobacteria management in adult patients with Cystic Fibrosis: a retrospective study
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019


Microbial aetiology and outcomes of CAP in bronchiectatic patients
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013